trending Market Intelligence /marketintelligence/en/news-insights/trending/sIa0Y399MW5ysgAviY2sFw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Fresenius Medical to buy back up to €330M of shares

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Fresenius Medical to buy back up to €330M of shares

Fresenius Medical Care AG & Co. KGaA is planning to buy back up to €330 million worth of ordinary shares as part of a share repurchase program.

The German maker of kidney dialysis products will buy back up to a maximum of 6 million ordinary shares, representing about 1.6% of Fresenius' share capital. The repurchased shares will be used to reduce the registered share capital, which will be done by canceling the shares that are bought back by the company.

Fresenius said the repurchases will take place March 12-May 10, noting that the share buyback program may be suspended or restarted at any time.